PETALING JAYA: Pharmaniaga Bhd
said it continued to sustain its positive trajectory in the third quarter ended Sept 30, 2025 (3Q25), despite posting a 93% year-on-year (y-o-y) decline in its net profit for the quarter.
For 3Q25, the group’s net profit dropped to RM7.3mil, or an earnings per share of 0.28 sen. This was due to higher transportation costs incurred for the delivery of new products recently added to the approved products purchase list to East Malaysia, as deliveries were made via air and sea freight to meet customer demand.
Revenue for 3Q25 was also down by 2% y-o-y to RM1.01bil.
For the nine-month period ended Sept 30, 2025 (9M25), the group’s net profit decreased by 68% y-o-y to RM40.8mil or earnings per share of 1.56 sen.
This was despite a higher revenue for 9M25, which grew by 6% y-o-y to RM2.99bil, supported by heightened customer demand in the concession segment.
